Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-11-30
pubmed:abstractText
Advanced esophagogastric carcinoma has a poor prognosis. Palliative chemotherapy provides a survival advantage and improved quality of life. Epirubicin, cisplatin and continuous infusional 5-fluorouracil (5-FU) (ECF) is a well-established chemotherapy regimen but a continuous chemotherapy infusion is not always feasible or acceptable.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1743-7563
pubmed:author
pubmed:copyrightInfo
© 2010 Blackwell Publishing Asia Pty Ltd.
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
298-305
pubmed:meshHeading
pubmed-meshheading:21114780-Adenocarcinoma, pubmed-meshheading:21114780-Aged, pubmed-meshheading:21114780-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21114780-Carcinoma, Squamous Cell, pubmed-meshheading:21114780-Cisplatin, pubmed-meshheading:21114780-Drug Therapy, Combination, pubmed-meshheading:21114780-Epirubicin, pubmed-meshheading:21114780-Esophageal Neoplasms, pubmed-meshheading:21114780-Female, pubmed-meshheading:21114780-Follow-Up Studies, pubmed-meshheading:21114780-Humans, pubmed-meshheading:21114780-Infusions, Intravenous, pubmed-meshheading:21114780-Leucovorin, pubmed-meshheading:21114780-Male, pubmed-meshheading:21114780-Middle Aged, pubmed-meshheading:21114780-Stomach Neoplasms, pubmed-meshheading:21114780-Survival Rate, pubmed-meshheading:21114780-Treatment Outcome, pubmed-meshheading:21114780-Vitamin B Complex
pubmed:year
2010
pubmed:articleTitle
A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.
pubmed:affiliation
Department of Medical Oncology, Guy's Hospital, London, UK. c.karapetis@flinders.edu.au
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I